thursday1

10th

Congress of the European Society of Contraception 

Scientific

programme in detail

Wednesday,

April 30

Thursday,

May 1

Friday,

May 2

Saturday,

May 3

Programme

overview>>>

10:30 –

12:00

Congress

Hall

Sponsored

Symposium 1 (Bayer Schering Pharma): The

premenstrual symptomatology from different angles

Chair: S. O’Brien (United Kingdom)
  
10:30 Etiology, diagnostic and treatment rationale:

International consensus on PMS/PMDD – S. O’Brien (United Kingdom)

11:00 PMS/PMDD in real life – A. Schwenkhagen (Germany)
11:30 A new oral contraceptive with two additional

indications – experiences from the United States – L. Schulman

(USA)

10:30 –

12:00

Meeting

Hall 1

Congress

Session 1: Critical evaluation and clinical management of side effects

Chair: D. Cibula (Czech Rep.) – K. Sedlecki

(Serbia)

  Book of abstracts
10:30 Mood changes/depression – R. Van

Lunsen (The Netherlands)

IS-04
10:50 Weight changes – M. Lech (Poland) IS-05
11:10 Bone Mineral Density (BMD) – D. Cibula

(Czech Rep.)

IS-06
11:30 Breakthrough bleeding – tbd IS-07 
11:45 How often and why do women discontinue their

contraceptive method? Results from a French population-based survey

C. Moureau (France)

FC-01
11:53 Comparison of patients from high risk population with vs.

without thrombotic events while exposed to hormonal contraception

M.J. Carvalho (Portugal)

FC-02
 

  

10:30 –

12:00

Panorama

Hall

Society

Session 1: Faculty of Sexual and Reproductive Healthcare (FSRH – UK)

European

Contraception Masterclass – Transnational Evidence-Based Contraceptive

Practice        

Chair: A. Glasier (UK) – C. Wilkinson (UK)

Book of abstracts

10:30

Opening remarks by the FSRH President

– M. Kishen (UK)

10:40

Depo-Provera and bone density – D.

Mansour (UK)

SS1-01

11:00

Intra-uterine devices and infection risk

– F. Martinez (Spain) – E. Lopez Arregui (Spain)

SS1-02

11:20

Emergency contraception – over the

counter and advance supplies – I. Batar (Hungary)

SS1-03

11:40

WHO-Medical eligibility criteria in the UK – A. Kubba (UK)

SS1-04

Concluding remarks from the Chairpersons

10:30 –

12:00

Hall

IV

Free

Communication Session 1

Chair: P. Kascak (Slovakia) – D. Apter (Finland)

Book of abstracts

10:30

Review of emergency re-admissions after 1st trimester

abortion; Implications for service design and delivery – O. Graham

(UK)

FC-03

10:43

Which women are at risk for repeated abortion? – S.

Tschudin (Switzerland)

FC-04

10:56

Widening access for practitioners in Scotland to Sexual

and Reproductive Health education through e-learning delivery: could

this be developed for use in other countries? – N. Graham (UK) 

FC-05

11:09

Ten years of medical abortion services and innovations in

Tunisia – S. Hajri (Tunisia)

FC-06

11:22

How do men with subnormal semen values react to hormonal

male contraception? – E. Nieschlag (Germany)

FC-07

11:35

Contraceptive failure related to early ovulation – E.

Wiebe (Canada)

FC-08

11:48

Supporting primary healthcare professionals providing

crisis pregnancy care in Ireland – N. Kenny (Ireland)

FC-09

10:30 –

12:00

Club E

Society

Session 2: Association of Reproductive Health Professionals (ARHP – USA) 

Translating

science into practice: helping patients understand health risks for

effective, customized care 

Co-moderators: L. Shulman (USA), A. Furedi (UK)

Book of abstracts

10:30

Opening remarks by the ARHP board chair

– L. Shulman (USA)

10:40

You decide: making informed health choices

about hormonal contraception – Co-Moderators

SS2-01

11:10

Translating the scientific literature on

contraception into effective patient care – Co-Moderators 

SS2-02

11:40

Questions, answers, interactive discussion

– Co-Moderators

Scientific

programme in detail

Wednesday,

April 30

Thursday,

May 1

Friday,

May 2

Saturday,

May 3

 

home

Scroll to Top